ArticleOxidative medicine and cellular longevity2022

Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy.

Lei-Ming Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.